About
Steinbeis Europa Zentrum stands for more than 35 years of experience in innovation consulting and research funding in Europe and beyond. With 90 EU projects and around 1000 partnerships in 60 countries every year, Steinbeis Europa Zentrum is well networked and helps its clients to enter international markets.
Well-connected with international partners and networks, we stand by companies, start-ups, universities, research institutions and cluster initiatives on issues of innovation management, financing, EU applications, international markets, regional and social transformation and innovation policy.
For all target groups, we offer further training on proposal writing, project management and innovation. Together with economic development agencies, representatives of the state ministries and the EU, we conceptualise and organise large congresses and information events, including international ones, bringing together innovation actors from the entire value chain.
With various activities from the non-profit, economic as well as European sectors, we create added value for our clients: companies and start-ups, universities and research institutions, cluster initiatives and networks, public sector actors.
Cluster 1: Health
HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion HOHORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate changeHORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate changeHORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potentialHORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from FlavivirusesHORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga virusesHORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobialsHORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseasesHORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseasesHORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medicationsHORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseasesHORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicineHORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosisHORIZON-HLTH-2027-03-TOOL-08: Towards Artificial General Intelligence (AGI) for healthcareHORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicalsHORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics